- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NARI
Recent news which mentions NARI
From Benzinga
Tickers
NARI
From Motley Fool
How to Find New Stocks for Your Portfolio
April 06, 2022
From Motley Fool
Sea Light Design-Build named NARI Regional CotY™ Winner
February 28, 2022
From PRLog
Inari Medical, Inc. (NARI) Q4 2021 Earnings Call Transcript
February 24, 2022
Tickers
NARI
From Motley Fool
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
From Benzinga
Earnings Scheduled For February 23, 2022
February 23, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
January 11, 2022
From Benzinga
From Benzinga
21 Stocks Moving in Tuesday's Pre-Market Session
January 11, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 10, 2022
From Benzinga
3 High-Growth Stocks Wall Street Thinks Could Rise 50% or More
December 15, 2021
From Motley Fool
3 COVID-19 Stocks That Should Beat the Market in 2022
December 09, 2021
From Motley Fool
3 Unstoppable Growth Stocks You Can Buy for Less Than $100 Right Now
November 29, 2021
From Motley Fool
4 stock picks for the post-pandemic ‘nesting’ economy from a five-star money manager
November 15, 2021
From MarketWatch
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
Inari Medical, Inc. (NARI) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
NARI
From Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
3 Under-the-Radar COVID Stocks
October 20, 2021
From Motley Fool
Should You Take the "Basket Approach" to Investing in Tech Stocks?
September 24, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.